Monday, August 6th, 2018
For Immediate Release:
Star Health Network and Emerge Healthcare form Strategic Alliance to Advance Drug Discovery
New York, NY and Summit, NJ:
Star Health Network, Inc. (Star) an oncology data aggregator and Clinical Research Organization (CRO) with a strong international establishment of cancer centers, oncologists and patients and Emerge Healthcare (Emerge), a top tier strategic consulting firm with deep roots in the bio-pharma industry, today announced a strategic alliance to provide unprecedented access of their combined capabilities to support Life Science companies in the United States.
Star and Emerge business model is based on the premise that more than 1000 new molecules targeting cancer are in various stages of development, each will need human biologicals, clinical and biomarker data and access to a pool of genetically profiled patient population to attain FDA approval. In the current environment, multiple sponsors face significant bottlenecks in their patient enrollment journey and end up competing from a limited pool of patients that match their targeted therapies, the complexity of which is further compounded by a scarcity of potential study subjects, as less than 2% of U.S. cancer patients enroll in clinical trials.
Their combined capabilities will provide a powerful solution to serve bio-pharma in all stages of their drug development by leveraging Emerge’s experience and strategic insights in the pharmaceutical and CRO worlds and Star’s established international network of hundreds of Hospitals and Oncologists supplemented by its Cancer Genomics and Molecular Diagnostic Laboratory, which is profiling thousands of cancer patients and capturing complimentary clinical and genomics data longitudinally.
Through this alliance Life Science clients in the United States will have the ability to preferentially select from a repertoire of offerings - access to a bio-sample repository of 15,000 solid and liquid tumors to support biomarker/translational research, cancer genomic data, IO related real world drug efficacy and outcomes data, collaboration in companion diagnostic development and to “Fast Track” patient enrollment from a captive pool of 160,00 cancer patients and 7,500 patients with complimentary “Clinical and Genomics” data.
Star and Emerge will begin to offer game changing strategic and executional help at all levels of life sciences companies to expeditiously drive their research from bench top to bedside.
About Emerge Healthcare:
Emerge is based in Summit, New Jersey and offers unprecedented, full life cycle support, to life science companies in developing a competitive edge necessary to achieve commercialization goals. Principals of Emerge have held top-level positions in the pharmaceutical and clinical trials industry.
About Star Health Network:
Star Health Network (Star) is a privately held company headquartered in New York. Star is delivering advanced cancer care by delivering a trident of “Genomic-Digital-Artificial Intelligence,” offerings directly to hospitals, oncologists and patients. Star's network operates in India-Asia, which contributes 44% of all cancer cases. Its operations capture and warehouse longitudinal “Clinical and Genomics” data.
Contact:
John Spitznagel - john@emergehc.com
Bill Scully - bill@emergehc.com